In what could represent a major advance in the fight against coronavirus, a Rutgers University research lab says it has developed a new test using existing automated technology able to analyze tens of thousands of patient samples each day to detect COVID-19. At the same time, RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — submitted an emergency use authorization request for a saliva collection method that would allow for far broader screening than what is now even possible. To read the full article.
- Rutgers Health and RWJBarnabas Health Receive Grant to Train Health Professionals and Improve Care
- Register Now for Rutgers Health Anniversary Symposium on March 20th
- New NJACTS Publication
- Study Charts Possibilities for a Better Way to Diagnose Gestational Diabetes.
- An NIH-funded R25 Summer Research/Education Program – Apply Now